(Q41376862)

30 September 2017

1 reference

title

Neuropeptides in learning and memory processes (English)

1 reference

30 September 2017

de Wied D

1

1 reference

30 September 2017

language of work or name

English

0 references

publication date

1 February 1997

1 reference

Behavioural Brain Research

30 September 2017

published in

1 reference

30 September 2017

volume

83

1 reference

30 September 2017

issue

1-2

1 reference

30 September 2017

page(s)

83-90

1 reference

Identification of antagonists for melanocortin MC3, MC4 and MC5 receptors

30 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2897%2986050-0

7 January 2021

Preprotachykinin gene expression in the forebrain: regulation by dopamine

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2897%2986050-0

7 January 2021

[3H]vasopressin binding to rat hippocampal synaptic plasma membrane. Kinetic and pharmacological characterization.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2897%2986050-0

7 January 2021

The effects of atrial natriuretic peptide on electroconvulsive shock-induced amnesia in rats. Transmitter-mediated action

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2897%2986050-0

7 January 2021

Arginine-vasopressin binding sites in rat brain: A quantitative autoradiographic study

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2897%2986050-0

7 January 2021

Molecular cloning of the receptor for human antidiuretic hormone

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2897%2986050-0

7 January 2021

Oxytocin, vasopressin and memory: opposite effects on consolidation and retrieval processes

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2897%2986050-0

7 January 2021

ACTH and attention in humans: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2897%2986050-0

7 January 2021

Vasopressin and oxytocin: distribution and putative functions in the brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2897%2986050-0

7 January 2021

A Major Metabolite of Arginine Vasopressin in the Brain Is a Highly Potent Neuropeptide

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2897%2986050-0

7 January 2021

Vasopressin induction of long-lasting potentiation of synaptic transmission in the dentate gyrus

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2897%2986050-0

7 January 2021

Decreased performance in a delayed alternation task by rats genetically deficient in vasopressin

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2897%2986050-0

7 January 2021

Chronic intracerebral infusions of vasopressin and vasopressin antagonist modulate social recognition in rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2897%2986050-0

7 January 2021

Topography of binding sites for neurohypophyseal hormones in rat brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2897%2986050-0

7 January 2021

Non-peptide angiotensin II receptor antagonist and angiotensin-convering enzyme inhibitor: effect on a renin-induced deficit of a passive avoidance response in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2897%2986050-0

7 January 2021

Behavioral effects of intraventricularly administered vasopressin and vasopressin fragments

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2897%2986050-0

7 January 2021

Neuropeptides derived from pro-opiocortin: behavioral, physiological, and neurochemical effects

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2897%2986050-0

7 January 2021

Central nervous system effects of the neurohypophyseal hormones and related peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2897%2986050-0

7 January 2021

Axonal regeneration, growth factors and neuropeptides

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2897%2986050-0

7 January 2021

Physiological and behavioral responses to corticotropin-releasing factor administration: is CRF a mediator of anxiety or stress responses?

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2897%2986050-0

7 January 2021

Chapter 61: Neurohypophyseal hormone receptors: relation to behavior

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2897%2986050-0

7 January 2021

Effects of ACTH on EEG habituation in human subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2897%2986050-0

7 January 2021

Dissociation of the effects of neuropeptide Y on feeding and memory: evidence for pre- and postsynaptic mediation.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2897%2986050-0

7 January 2021

Modulation of memory processing by neuropeptide Y varies with brain injection site.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2897%2986050-0

7 January 2021

Modulation of memory retention by neuropeptide K.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2897%2986050-0

7 January 2021

Vasoactive intestinal peptide (VIP): an amnestic neuropeptide.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2897%2986050-0

7 January 2021

Evidence that cholecystokinin-enhanced retention is mediated by changes in opioid activity in the amygdala

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2897%2986050-0

7 January 2021

Influence of substance P and fragments on passive avoidance behavior

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2897%2986050-0

7 January 2021

Some effects of ACTH 4-10 on performance during a serial reaction task

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2897%2986050-0

7 January 2021

Some effects of an ACTH 4–9 analog (Org 2766) on human performance

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2897%2986050-0

7 January 2021

Neuropeptides in perspective: the last ten years

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2897%2986050-0

7 January 2021

Arginine-vasopressin enhances the responses of lateral septal neurons in the rat to excitatory amino acids and fimbria-fornix stimuli

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2897%2986050-0

7 January 2021

Structure and expression of a human oxytocin receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2897%2986050-0

7 January 2021

Facilitation of avoidance behavior by vasopressin fragments microinjected into limbic-midbrain structures.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2897%2986050-0

7 January 2021

N alpha-acetyl-[Arg8]vasopressin antagonizes the behavioral effect of [Cyt6]vasopressin-(5-9), but not of vasopressin

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2897%2986050-0

7 January 2021

Mortyn Jones Memorial Lecture. Intracerebrally released vasopressin and oxytocin: measurement, mechanisms and behavioural consequences.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2897%2986050-0

7 January 2021

N-acetyl-vasopressin- and N-acetyl-oxytocin-like substances: isolation and characterization in the rat neurointermediate pituitary and presence in the brain

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2897%2986050-0

7 January 2021

Effects of anti-CCK-8 antiserum on acquisition and retrieval by mice in an appetitive task.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2897%2986050-0

7 January 2021

Molecular cloning and expression of a rat V1a arginine vasopressin receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2897%2986050-0

7 January 2021

Effects of peripheral hormones on memory and ingestive behaviors

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2897%2986050-0

7 January 2021

Neuropeptide Y and memory processing

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2897%2986050-0

7 January 2021

The cloning of a family of genes that encode the melanocortin receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2897%2986050-0

7 January 2021

Facilitation of tunnel maze performance by systemic injection of the neurokinin substance P.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2897%2986050-0

7 January 2021

Evidence for a role of the neuropeptide galanin in spatial learning

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2897%2986050-0

7 January 2021

Recognition cue in the rat's social memory paradigm

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2897%2986050-0

7 January 2021

The effects of ACTH- and vasopressin- analogues on CO2-induced retrograde amnesia in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2897%2986050-0

7 January 2021

MSH/ACTH 4-10 Influences Behavioral and Physiological Measures of Attention1

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2897%2986050-0

7 January 2021

In vivo conversion of vasopressin after microinjection into limbic brain areas of rats

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2897%2986050-0

7 January 2021

Facilitation of learning by post-trial injection of substance P into the medial septal nucleus.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2897%2986050-0

7 January 2021

Behavioral effects of neurotensin.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2897%2986050-0

7 January 2021

Sites of behavioral and neurochemical action of ACTH-like peptides and neurohypophyseal hormones

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2897%2986050-0

7 January 2021

Vasopressin maintains long-term potentiation in rat lateral septum slices

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2897%2986050-0

7 January 2021

Neuropeptide Y receptor subtypes, Y1 and Y2.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2897%2986050-0

7 January 2021

OPC-21268, an Orally Effective, Nonpeptide Vasopressin V1 Receptor Antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2897%2986050-0

7 January 2021

Characterization of a novel aquaretic agent, OPC-31260, as an orally effective, nonpeptide vasopressin V2 receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2897%2986050-0

7 January 2021

10.1016/S0166-4328(97)86050-0

Identifiers

DOI

1 reference

30 September 2017

1 reference